Literature DB >> 21403434

Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease.

Hack-Lyoung Kim1, Goh Eun Chung, In Young Park, Jin Man Choi, Se-Min Hwang, Jeong-Hoon Lee, Donghee Kim.   

Abstract

An elevated white blood cell (WBC) count is associated with nonalcoholic fatty liver disease (NAFLD); however, a leukocyte subtype that is involved in the pathogenesis of NAFLD is not known. This study was conducted to investigate the association between NAFLD and WBC subtype fractions (%) among healthy elderly Koreans. A total of 794 subjects who underwent a health check-up were investigated. After excluding excessive alcohol intake and other liver diseases, NAFLD was diagnosed based on sonographic findings: hyperechogenecity of liver tissue, difference of echogenicity between liver and kidney, and visibility of vascular structures. The prevalence of NAFLD among entire cohort was 39.0% (310/794). The presence of NAFLD was significantly associated with higher blood WBC counts (5,485 ± 1073 vs. 5,230 ± 995 per mm(3), p = 0.001) and monocyte fraction (6.08 ± 2.40% vs. 5.12 ± 1.31%, p < 0.001). The multiple logistic regression analysis, after controlling confounders, including age, gender, body mass index, systolic and diastolic blood pressure, fasting blood glucose, alanine aminotransferase, triglyceride, and high-density lipoprotein cholesterol, showed that the prevalence risk of NAFLD was increased significantly according to the monocyte fraction quartiles: odds ratios (ORs) and 95% confidence intervals (CIs) for NAFLD were 1.00, 2.75 (1.63-4.62), 2.84 (1.67-4.84) and 5.17 (3.03-8.83), respectively. There were no significant associations between NAFLD and the total WBC count quartiles in this model. These results indicate that the elevated peripheral blood monocyte fraction is associated with NAFLD. The monocyte fraction might be a useful marker for NAFLD.

Entities:  

Mesh:

Year:  2011        PMID: 21403434     DOI: 10.1620/tjem.223.227

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  6 in total

1.  Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease.

Authors:  Jianmei Zhang; Wenbin Chen; Li Fang; Qiu Li; Xu Zhang; Haiqing Zhang; Qingbo Guan; Rang Zhao; Chongbo Yang; Fei Jing
Journal:  Wien Klin Wochenschr       Date:  2018-05-29       Impact factor: 1.704

2.  The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease.

Authors:  Qian Li; Julia D Rempel; Jiaqi Yang; Gerald Y Minuk
Journal:  J Clin Exp Hepatol       Date:  2021-11-25

3.  Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease.

Authors:  Goh Eun Chung; Jeong Yoon Yim; Donghee Kim; Min-Sun Kwak; Jong In Yang; Su Jin Chung; Sun Young Yang; Joo Sung Kim
Journal:  Gastroenterol Res Pract       Date:  2016-12-13       Impact factor: 2.260

Review 4.  Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.

Authors:  Joeri Lambrecht; Frank Tacke
Journal:  Front Immunol       Date:  2021-02-09       Impact factor: 7.561

5.  Association of peripheral total and differential leukocyte counts with obesity-related complications in young adults.

Authors:  Aya Yoshimura; Shunsuke Ohnishi; Chieko Orito; Yukako Kawahara; Hiroyo Takasaki; Hiroshi Takeda; Naoya Sakamoto; Satoshi Hashino
Journal:  Obes Facts       Date:  2015-01-29       Impact factor: 3.942

6.  Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease.

Authors:  Noha El Nakeeb; Shereen A Saleh; Yasmine M Massoud; Ahmed Hussein; Rana Hamed
Journal:  JGH Open       Date:  2017-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.